Living with drug-resistant focal epilepsy is incredibly hard on children and their families. When medication stops working, surgery often becomes the next step. A recent model looked at two surgical options: traditional open resection and a newer laser treatment called MRgLITT. The goal was to see which path offered better long-term outcomes for kids with specific types of seizure locations.
The findings show that both surgical methods performed significantly better than staying on medical management alone. Specifically, the laser treatment (MRgLITT) showed a 4.6 year survival advantage over just using medication. While both surgeries resulted in similar quality of life scores, the choice between them depends on the specific cause of the seizures. For example, laser therapy is suggested for certain types of tissue scarring, while open surgery is preferred for tumors.
It is important to note that this study used a mathematical model rather than a direct clinical trial. This means it provides a helpful roadmap for costs and outcomes, but there is still limited evidence comparing the two surgical methods directly. Doctors will still need to look at the specific cause of a child's epilepsy to decide which path is safest.
